DGPPN 2018 Programm

POSTER PRESENTATIONS 306 WEDNESDAY THURSDAY FRIDAY SATURDAY P-25 (e) Poster Presentation 13:30– 15:00 h | Hall Helsinki 1 /2 TOPIC 3: Psychotic disorders, F2 Psychotic disorders Chair: Berend Malchow, Jena (Germany) 001 N-methyl-D-aspartate receptor an- tibody encephalitis presenting as acute psychosis: a case report Eva Lamadé, Bad Soden am Taunus (Germany) Volker Jost, Eva Maria Craemer, Uta Meyding- Lamadé 002 A neural signature of abnormal cortical development in patients with schizophrenia who have persistent audi- tory verbal hallucinations Robert Christian Wolf, Heidelberg (Germany) 003 Clinical symptomatology in correla- tion with social functionating among first time diagnosed schizophrenia spec- trum patients in a rural region of Latvia Karina Bezina, Daugavpils (Lativa) Liene Berze, Konstantins Pavlovs, Elmars Rancans, Sarmite Kikuste, Inna Sapele, Natalja Kurakina 004 Multisensory visual-tactile inte- gration compensates for unisensory processing deficits in schizophrenia James Moran, Berlin (Germany) Julian Keil, Felix Bermpohl, Daniel Senkowski 005 Oculomotor dysfunction and neurocognitive deficits in schizophrenia continuum Tatsiana Skuhareuskaya, Minsk (Belarus) Ilya Obyedkov 006 Differences in (an-)hedonia between subjects with schizophrenia and healthy controls Janina Richter, Tübingen (Germany) Lea Hölz, Stefan Klingberg 007 Violent offending in schizophrenia- spectrum disorders preceding and following diagnosis Henning Hachtel, Basel (Switzerland) 008 Stable schizophrenia patients switched to paliperidone palmitate 3-monthly formulation in real life: functioning and resource use Katalin Pungor, Neuss (Germany) María Paz Garcia-Portilla, Pierre Michel Llorca, Giuseppe Maina, Vasilis P. Bozikas, Halise Devrimci-Ozguven, Sung-Wan Kim, Paul Bergmans, Irina Usankova, Pierre Cherubin 009 Hospitalization rates and resource utilization of schizophrenic patients switched from oral antipsychotics to aripiprazole-depot in Germany Christoph Potempa, Burscheid (Germany) Reinhard P. T. Rychlik 010 Early response to antipsychotic me- dication in adolescents with first-episode psychosis predictor of ultimate response and remission: results from the 12 weeks TEA trial Amanda Krogmann, Berlin (Germany) Christoph U. Correll, Britta Galling, Anne Katrine Pagsberg 011 The effectiveness of 10 modules Me- tacognitive Training (MCT): randomized controlled trial in Japan Takuma Ishigki, Tokyo (Japan) Ryotaro Ishikawa 012 Dezadoptation women patients with paranoid schizophrenia at different models of family Kornelia Kosenko, Odessa (Ukraine) Mikhail Pustovoit 013 Modeling planed movement with recursive bayes and feedforward and feedback reverberations – implication of inhibition failure on the sense of agency Christoph Kuhn, Zurich (Switzerland) Sönke Böttger, Cornelius Bück